APD-Containing Cyclolipodepsipeptides Target Mitochondrial Function in Hypoxic Cancer Cells.
Cell Chem Biol
; 25(11): 1337-1349.e12, 2018 11 15.
Article
in En
| MEDLINE
| ID: mdl-30122371
The natural product family of macrocyclic lipodepsipeptides containing the 4-amido-2,4-pentadienoate functionality possesses intriguing cytotoxic selectivity toward hypoxic cancer cells. These subpopulations of cancer cells display increased metastatic potential and resistance to chemo- and radiotherapy. In this paper, we present studies on the mechanism of action of these natural products in hypoxic cancer cells and show that this involves rapid and hypoxia-selective collapse of mitochondrial integrity and function. These events drive a regulated cell death process that potentially could function as a powerful tool in the fight against chemo- and radiotherapy-resistant cancer cells. Toward that end, we demonstrate activity in two different mouse tumor models.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Depsipeptides
/
Tumor Hypoxia
/
Mitochondria
/
Antineoplastic Agents
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
En
Journal:
Cell Chem Biol
Year:
2018
Document type:
Article
Affiliation country:
Denmark
Country of publication:
United States